Home sleep apnea testing devices market to reach $3.24 billion by 2030

The global home sleep apnea testing devices market is projected to grow from $1.98 billion in 2025 to $2.19 billion in 2026, according to The Business Research Company. Rising sleep disorder diagnoses, broader telemedicine use and portable monitoring technology are expected to drive the market to $3.24 billion by 2030.

Why it matters: - Home sleep apnea testing is moving from a niche option to a mainstream diagnostic path as sleep disorders become more common and at-home care expands. - The market’s projected rise to $3.24 billion by 2030 points to stronger demand for convenient, lower-cost alternatives to in-lab sleep studies. - Growth in this category can affect device makers, telehealth providers, pharmacies and healthcare systems that are shifting more testing outside hospitals.

What happened: - The Business Research Company released its 2026 market report on home sleep apnea testing devices. - The report estimates the market will grow from $1.98 billion in 2025 to $2.19 billion in 2026. - The report forecasts the market will reach $3.24 billion by 2030. - The company published a free sample report and the full market report. - North America held the largest share of the global market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Home sleep apnea testing devices are compact tools used in a patient’s home. - The devices monitor airflow, oxygen saturation and breathing patterns. - The devices provide an alternative to traditional laboratory sleep studies. - Healthcare providers analyze the recorded data to diagnose sleep apnea and related conditions. - The report links recent market growth to limited access to home-based testing devices, reliance on in-lab studies, undiagnosed sleep apnea cases, rising sleep wellness awareness and healthcare infrastructure investment. - The report ties future growth to portable monitoring devices, wearable technologies, cloud-based data analytics, telemedicine, remote patient care, an aging population and broader distribution through online channels and retail pharmacies. - The report also flags growing preference for wearable sleep trackers, wider adoption of home sleep monitoring, stronger sleep apnea awareness and integration of patient data with provider systems. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and technology and trend analysis. - An NHS report from November 2023 found that 64.9% of people aged 17 to 23 experienced sleep problems on at least three nights in the previous week. - The same NHS report said sleep problems were more common among young women, at 74.7%, than young men, at 55.7%.

Between the lines: - The forecast suggests home testing is gaining credibility as sleep care shifts toward earlier screening and remote diagnosis. - The strongest growth signals are in regions and channels that support lower-friction access, especially telemedicine, retail pharmacies and online sales. - The inclusion of wearable tech and cloud analytics points to a market that is becoming more connected to broader digital health workflows.

What's next: - The market is expected to keep growing at a 10.3% CAGR through 2030. - Device makers and distributors are likely to keep pushing toward portable, connected and patient-friendly testing products. - Adoption should continue rising as sleep disorder awareness increases and more care moves into home settings.